tiprankstipranks
Trending News
More News >
Imperium Financial Group Limited (HK:8029)
:8029
Hong Kong Market

Imperium Financial Group Limited (8029) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Imperium Financial Group Limited

(8029)

Rating:41Neutral
Price Target:
The overall score of 41 reflects significant financial difficulties, including declining revenues, negative equity, and operational challenges. Technical indicators suggest bearish momentum, and the negative P/E ratio points to valuation concerns. Strategic improvements are necessary for a positive future outlook.

Imperium Financial Group Limited (8029) vs. iShares MSCI Hong Kong ETF (EWH)

Imperium Financial Group Limited Business Overview & Revenue Model

Company DescriptionImperium Financial Group Limited (8029) is a financial services company listed on the Hong Kong Stock Exchange. The company primarily operates within the financial sector, offering a range of services including securities trading, asset management, and financial advisory. It caters to a diverse clientele, providing tailored financial solutions and leveraging its expertise to assist clients in achieving their investment and financial objectives.
How the Company Makes MoneyImperium Financial Group Limited generates revenue through various streams within the financial services industry. Its primary revenue sources include commissions and fees from securities trading, management fees from asset management services, and advisory fees from financial consulting. The company benefits from its strategic partnerships with financial institutions, which enhance its service offerings and contribute to its earnings. Additionally, market conditions and investor demand significantly impact its revenue, as they influence trading volumes and asset management inflows.

Imperium Financial Group Limited Financial Statement Overview

Summary
Imperium Financial Group Limited is facing considerable financial challenges with declining revenues, persistent losses, and a highly leveraged balance sheet. While there is some cash generation capability, the negative equity and profitability issues pose significant risks. The company needs strategic measures to improve financial health and ensure its long-term viability.
Income Statement
40
Negative
The company has experienced a declining revenue trend over the past years, with a notable revenue drop from 2020 to 2024. The gross profit margin has decreased significantly, indicating reduced profitability. The net income remains negative, indicating losses, and the EBIT margin is zero, highlighting operational challenges. The EBITDA margin improved slightly in 2024, yet remains low, pointing to ongoing financial struggles.
Balance Sheet
30
Negative
The company's balance sheet reveals a negative stockholders' equity, a critical concern indicating insolvency risk. The debt-to-equity ratio is negative due to negative equity, illustrating excessive leverage. The equity ratio is also negative, demonstrating a weak financial position with liabilities exceeding assets. These factors pose significant risks to financial stability.
Cash Flow
50
Neutral
The operating cash flow remains positive, reflecting some ability to generate cash from operations, yet it has decreased significantly from prior years. The free cash flow has declined but remains positive, indicating some capacity to manage capital expenditures. However, the cash flow to net income ratios are impacted by persistent negative net income, suggesting challenges in converting income into cash.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue14.26M31.35M30.27M53.69M63.72M98.07M
Gross Profit-1.05M10.78M17.81M37.80M57.33M91.41M
EBITDA20.76M3.13M-96.19M-83.97M-30.25M-25.91M
Net Income-30.90M-13.60M-117.62M-106.16M-61.93M-60.48M
Balance Sheet
Total Assets121.16M143.35M185.40M343.57M390.89M558.61M
Cash, Cash Equivalents and Short-Term Investments58.08M47.60M66.25M85.53M106.93M110.51M
Total Debt0.00103.47M120.10M168.64M165.71M214.99M
Total Liabilities186.52M190.30M218.11M274.91M328.91M448.05M
Stockholders Equity-64.56M-46.95M-32.70M68.67M61.98M110.56M
Cash Flow
Free Cash Flow-375.00K11.61M36.18M-18.62M75.11M22.97M
Operating Cash Flow597.00K12.58M36.27M449.00K78.35M25.98M
Investing Cash Flow40.92M7.49M444.00K-19.07M-3.15M-3.95M
Financing Cash Flow-38.91M-36.93M-54.90M-2.42M-82.61M-13.54M

Imperium Financial Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.67
Price Trends
50DMA
0.69
Negative
100DMA
0.63
Positive
200DMA
0.60
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
43.73
Neutral
STOCH
50.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8029, the sentiment is Negative. The current price of 0.67 is below the 20-day moving average (MA) of 0.74, below the 50-day MA of 0.69, and above the 200-day MA of 0.60, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.73 is Neutral, neither overbought nor oversold. The STOCH value of 50.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8029.

Imperium Financial Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$95.33B50.246.14%1.50%7.63%-24.23%
68
Neutral
€14.65B23.7242.24%3.82%-5.88%-18.17%
58
Neutral
$12.53B5.19-2.71%5.24%5.88%-56.03%
47
Neutral
HK$1.39B-21.94%-29.75%-62.96%
41
Neutral
HK$156.38M
14.74%54.81%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8029
Imperium Financial Group Limited
0.78
0.07
9.86%
HK:1177
Sino Biopharmaceutical
5.45
2.77
103.06%
HK:1115
Tibet Water Resources
0.30
-0.01
-3.23%
HK:1428
Bright Smart Securities & Commodities Group Limited
8.89
7.42
506.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 21, 2025